Cagri/Reta Blend 5+5 = 10mg Lyophilized Powder

Sale!

~~£149.99~~ £79.99

Quantity

Item number: 1415456‑99‑3/2381089‑83‑2

🧬 Cagrilintide;

Molecular Formula: C₁₉₄H₃₁₂N₅₄O₅₉S₂

Molecular Weight: 4409.01 g/mol

CAS Number: 1415456‑99‑3

-----------------------------------

🧬 Retatrutide;

Molecular Formula: C₂₂₁H₃₄₂N₄₆O₆₈

Molecular Weight: ~4845.44 g/mol

CAS Number: 2381089‑83‑2

A “cagri + reta peptide blend” refers to a research‑only combination of cagrilintide and retatrutide, two investigational peptides often sold together for laboratory studies. Both components are not approved for medical use, and vendors explicitly state they are for research purposes only.

Cagri-Reta Blend is a powerful combination of two cutting-edge metabolic peptides: Cagrilintide (5mg) and Retatrutide (5mg).

This unique blend is designed to support research into weight management, glucose control, appetite regulation, and fat metabolism.

Cagrilintide, an amylin analog, is studied for appetite suppression and satiety, while Retatrutide, a triple agonist (GLP-1, GIP, and glucagon), is investigated for comprehensive metabolic improvements and energy expenditure.

Together, they form a potent research tool in the field of obesity and metabolic health studies.

🧪 What the Cagri + Reta Blend Is

Cagrilintide: An amylin analogue studied for appetite regulation and metabolic effects.
Retatrutide: A triple‑agonist peptide (GIP/GLP‑1/glucagon) under investigation for metabolic and weight‑related pathways.
Cagrireta blends: Commercial research mixtures combining both peptides in a single vial, typically lyophilized powder
These blends are not approved medications and are not intended for human consumption.
They are sold for laboratory, analytical, or in‑vitro research only.
Any dosing discussions online (e.g., Reddit or forums) are anecdotal and not medical guidance.
The GLP-3 and Cagrilintide peptide blend combines two distinct agents in one research-use-only format. GLP-3 is a triple-receptor agonist that engages GLP-1, GIP, and glucagon receptors, while Cagrilintide is a long-acting amylin-receptor analog that interacts with amylin receptors involved in gut-brain signaling pathways.
Together, the blend is investigated as a tool to study multi-pathway receptor activation, downstream signaling cascades, and metabolic pathway markers in animal and other non-clinical research models, not as a therapeutic regimen.

Reconstitute with BAC's Water Only
When reconstituting peptides, it is crucial to use bacteriostatic water (BAC) to ensure sterility and safety.

BAC water contains 0.9% Benzyl Alcohol and is bacteria-proof, making it the preferred choice for reconstitution.

This method helps preserve the integrity of the peptide and prevents contamination.

To reconstitute a peptide blend, follow these steps:
Disinfect both vials and the stoppers with alcohol wipes.

Measure the required amount of BAC water based on the dosage.
Mix the peptide powder with the measured BAC water in a sterile syringe.

Inject the solution into the vial and refrigerate at 2–8°C, protected from light.

Use the reconstituted solution within 4 weeks for best potency and safety.

Legal and Safety Information;

Quantum Peptides products are provided exclusively for laboratory research and educational use.

They are not approved for human or veterinary applications.

These materials are not intended to diagnose, treat, cure, or prevent any medical condition.